Abstract

Nuclear RNAs are subject to a number of RNA decay pathways that serve quality control and regulatory functions. As a result, any virus that expresses its genes in the nucleus must have evolved mechanisms that avoid these pathways, but the how viruses evade nuclear RNA decay remains largely unknown. The multifunctional Kaposi’s sarcoma-associated herpesvirus (KSHV) ORF57 (Mta) protein is required for the nuclear stability of viral transcripts. In the absence of ORF57, we show that viral transcripts are subject to degradation by two specific nuclear RNA decay pathways, PABPN1 and PAPα/γ-mediated RNA decay (PPD) in which decay factors are recruited through poly(A) tails, and an ARS2-mediated RNA decay pathway dependent on the 5ʹ RNA cap. In transcription pulse chase assays, ORF57 appears to act primarily by inhibiting the ARS2-mediated RNA decay pathway. In the context of viral infection in cultured cells, inactivation of both decay pathways by RNAi is necessary for the restoration of ORF57-dependent viral genes produced from an ORF57-null bacmid. Mechanistically, we demonstrate that ORF57 protects viral transcripts by preventing the recruitment of the exosome co-factor hMTR4. In addition, our data suggest that ORF57 recruitment of ALYREF inhibits hMTR4 association with some viral RNAs, whereas other KSHV transcripts are stabilized by ORF57 in an ALYREF-independent fashion. In conclusion, our studies show that KSHV RNAs are subject to nuclear degradation by two specific host pathways, PPD and ARS2-mediated decay, and ORF57 protects viral transcripts from decay by inhibiting hMTR4 recruitment.

Highlights

  • The Kaposi’s sarcoma-associated herpesvirus (KSHV) is a nuclear double-stranded DNA virus that belongs to the gammaherpesvirus family

  • Previous studies showed that the Kaposi’s sarcoma-associated herpesvirus (KSHV) expresses the ORF57 protein to protect its RNAs from nuclear decay

  • To identify host-mediated nuclear RNA decay pathways that target KSHV viral transcripts for degradation and to determine whether ORF57 acts on these pathways, we used a well-defined transcription pulse-chase assay [22, 57, 61, 70]

Read more

Summary

Introduction

The Kaposi’s sarcoma-associated herpesvirus (KSHV) is a nuclear double-stranded DNA virus that belongs to the gammaherpesvirus family. It infects human B lymphocytes and endothelial cells and causes Kaposi’s sarcoma (KS) as well as the lymphoproliferative disorders primary effusion lymphoma (PEL) and some cases of multicentric Castleman’s disease (MCD) [1,2,3,4]. The KSHV life cycle consists of latent and lytic phases of infection. The viral genome resides in the host nucleus as a circular episome and only a few viral genes are expressed. The KSHV genome is nuclear, and it expresses its genes using the host cells transcription, RNA processing and translation machinery. Viral transcripts, like their host counterparts, are subject to RNA quality control (RNA QC) pathways that degrade improperly processed, aberrant RNAs [9,10,11,12,13]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.